Diabetes Mellitus Flashcards
What are symptoms of Type 2 Diabetes Mellitus ?
- Polydipsia
- Polyuria
- Often picked up incidentally on routine blood tests
What does HbA1c levels depend on?
- Red Blood cell lifespan
- Average blood glucose concentration
Which pathologies present with lower than expected HbA1c?
- Sickle Cell Anaemia
- Hereditary spherocytosis
- GP6D deficiency
- Haemolytic anaemia
Which pathologies present with higher than expected HbA1c?
- Untreated iron deficiency anaemia
- Vitamin B12/folic acid deficiency
- Splenectomy
What are Iatrogenic/Physiological causes of altered HbA1c on test results?
- Suspected gestational diabetes
- Children
- HIV
- Chronic kidney disease
- People taking medication that may cause hyperglycaemia (for example corticosteroids)
How is a diagnosis of Type 2 Diabetes mellitus made based on plasma glucose?
If the patient is symptomatic:
- fasting glucose greater than or equal to 7.0 mmol/l
- random glucose greater than or equal to 11.1 mmol/l (or after 75g oral glucose tolerance test)
If the patient is asymptomatic the above criteria apply but must be demonstrated on two separate occasions.
How is Glycaemic Control monitored based on HbA1c?
- Normal Glycaemic control <=41 mmol/mol (6.0 mmol/l)
- HbA1c of greater than or equal to 48 mmol/mol (6.5%) is diagnostic of diabetes mellitus
- HbA1c value of less than 48 mmol/mol (6.5%) does not exclude diabetes. It should be remembered that misleading HbA1c results can be caused by increased red cell turnover (see below)
What is Imapired gasting glucose and impaired glucose tolerance?
Impaired Fasting Glucose
- A fasting glucose greater than or equal to 6.1 but less than 7.0 mmol/l implies impaired fasting glucose (IFG)
- ‘People with IFG should then be offered an oral glucose tolerance test to rule out a diagnosis of diabetes. A result below 11.1 mmol/l but above 7.8 mmol/l indicates that the person doesn’t have diabetes but does have IGT.
Impaired glucose tolerance
- Impaired glucose tolerance (IGT) is defined as fasting plasma glucose less than 7.0 mmol/l and OGTT 2-hour value greater than or equal to 7.8 mmol/l but less than 11.1 mmol/l
What is the dietary advice given to Type 2 diabetics?
- Encourage high fibre, low glycaemic index sources of carbohydrates. Includes low-fat dairy products and oily fish
- Control intake of food containing saturated fats and trans fatty acids
- Target wright loss of 5-10% in overweight people initially
What are HbA1c targets used in the treatment of Type 2 Diabetes Mellitus?
Targets are dependant on treatments:
- Lifestyle: 48 mmol/mol (6.5%)
- Lifestyle + Metformin: 48 mmol/mol (6.5%)
- Includes any drug which may cause hypoglycaemia (e.g. lifestyle + sulfonylurea): 53 mmol/mol (7.0%)
- Already on one drug, but HbA1c has risen to 58 mmol/mol (7.5%): 53 mmol/mol (7.0%)
Checked every 3-6 months until stable then 6 monthly. Consider relaxing on case by case basis
What is the drug treatment pathway for patients that tolerte Metformin?
- Metformin is still first-line and should be offered if the HbA1c rises to 48 mmol/mol (6.5%)* on lifestyle interventions
- If the HbA1c has risen to 58 mmol/mol (7.5%) then a second drug should be added from the following list:
- Sulfonylurea, Gliptin, Pioglitazone, SGLT-2 inhibitor
- If despite this the HbA1c rises to, or remains above 58 mmol/mol (7.5%) then triple therapy with one of the following combinations should be offered:
- metformin + gliptin + sulfonylurea
- metformin + pioglitazone + sulfonylurea
- metformin + sulfonylurea + SGLT-2 inhibitor
- metformin + pioglitazone + SGLT-2 inhibitor
- OR insulin therapy should be considered
What is the drug treatment pathway for patients that cannot tolerte Metformin?
- If the HbA1c rises to 48 mmol/mol (6.5%)* on lifestyle interventions, consider one of the following:
- Sulfonylurea/Gliptin/Pioglitazone
- If the HbA1c has risen to 58 mmol/mol (7.5%) then a one of the following combinations should be used:
- Gliptin + pioglitazone
- Gliptin + sulfonylurea
- Pioglitazone + sulfonylurea
- If despite this the HbA1c rises to, or remains above 58 mmol/mol (7.5%) then consider insulin therapy
How is Insulin started in Type 2 Diabetes Mellitus?
- Metformin should be continued. Other drugs need reviewing
- Start with human NPH insulin (isophane, intermediate acting) taken at bed-time or twice daily according to need
Which risk factors have to modified in the tretment of Type 2 diabetes?
- Blood pressure
- target is < 140/80 mmHg (or < 130/80 mmHg if end-organ damage is present)
- ACE inhibitors are first-line
- Lipids
- PRMARY PREVENTION: Only patients with a 10-year cardiovascular risk > 10% (using QRISK2) should be offered a statin. The first-line statin of choice is atorvastatin 20mg on
- If non hdl has not fallen by >= 40% then tritrate up to 80mg
- SECONDARY PREVENTION: 80mg od
- Known IHD, CVD, PAD
- PRMARY PREVENTION: Only patients with a 10-year cardiovascular risk > 10% (using QRISK2) should be offered a statin. The first-line statin of choice is atorvastatin 20mg on
- Antiplatelets
- Should not be offered unless a patient has existing cardiovascular disease
What is the pathophysiology of Type 1 Diabetes Mellitus?
- Autoimmune disorder where the insulin-producing beta cells of the islets of Langerhans in the pancreas are destroyed by the immune system
- This results in an absolute deficiency of insulin resulting in raised glucose levels
- Patients tend to develop T1DM in childhood/early adult life and typically present unwell, possibly in diabetic ketoacidosis